By downregulating CSN5, curcumin enhances the sensitivity of cancer to anti-CTLA-4 treatment and the function of antitumor T cells by downregulating PD-L1 expression, thus alleviating cancer growth [239]. This evidence concerns the gene CD274 and cancer.